Dividend amount (per share): NOK 0.75
Declared currency: NOK
Last day including right: 22 January 2024
Ex-date: 23 January 2024
Record date: 24 January 2024
Payment date: 30 January 2024 (on or about)
Date of approval: 10 January 2024
For further information, please contact:
Alexander Karlsen
CFO
+47 97 05 36 21
This information is subject to the disclosure requirements pursuant to section 5-12 of the Norwegian Securities Trading Act.
TAMPA, FL / ACCESS Newswire / December 26, 2025 / Key TakeawaysWhat it claims: Nerve…
Integrated smart technology builds on TempraMed's proven VIVI platform, providing robust Temperature control with medication…
NORTHAMPTON, MA / ACCESS Newswire / December 26, 2025 / Specialized nutrition experts are key…
"Despite clear congressional mandates and FDA authorization, the Drug Enforcement Administration failed to act within…
WASHINGTON, Dec. 26, 2025 /PRNewswire/ -- Over the past decade, China has evolved from a biotechnology…
SEATTLE, WA / ACCESS Newswire / December 26, 2025 / Aptevo Therapeutics Inc. (NASDAQ:APVO), a…